Key Insights

Highlights

Treatment Research

8 treatments under study, led by Cyclophosphamide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05757310Phase 1Recruiting

A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia

Showing all 1 trials

Research Network

Common Treatments

  • Cyclophosphamide1
  • Bone Marrow Biopsy1
  • Questionnaire Administration1
  • Bone Marrow Aspirate1
  • Pentostatin1

Active Sponsors

  • National Cancer Institute (NCI)1
  • City of Hope Medical Center1

Top Investigators

Related Conditions

  • Recurrent Severe Aplastic Anemia1

Activity Timeline